FDA Authority Over Tobacco Industry Urged

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 7
Volume 10
Issue 7

WASHINGTON-A presidential commission has urged the enactment of a 17-cents-a-pack increase in the federal excise tax on cigarettes to pay for programs to aid tobacco farmers and support smoking cessation and prevention programs. It also recommended that the FDA be given strong regulatory powers over the tobacco industry.

WASHINGTON—A presidential commission has urged the enactment of a 17-cents-a-pack increase in the federal excise tax on cigarettes to pay for programs to aid tobacco farmers and support smoking cessation and prevention programs. It also recommended that the FDA be given strong regulatory powers over the tobacco industry.

The panel—the President’s Commission on Improving Economic Opportunities in Communities Dependent on Tobacco Production While Protecting Public Health—was established last year by former President Clinton. It had an equal number of tobacco growers and public health advocates among its 10 members, as well as several economic development experts.

Declaring that "tobacco farmers and their communities confront a bleak future," the commission called on the federal government to replace the current tobacco quota system with production permits available only to active growers. Unlike quotas, the permits would not be marketable assets, which would help ensure that the new system does not foster the same economic dependence on tobacco as the current one. The panel also urged compensation for quota owners and growers for the lost value of their quotas, and the creation of other economic assistance programs.

In the area of public health, the panel recommended that:

Congress should grant FDA the authority to regulate the manufacture, sale, marketing, distribution, and labeling of tobacco products. The FDA’s powers should be comparable to its authority over other products, but its authority should not extend to prohibiting the use of tobacco products by adults.

States should better fund comprehensive tobacco prevention and cessation programs. Those states that meet the minimum funding recommendations issued by the Centers for Disease Control and Prevention should receive additional federal assistance.

Medicare and Medicaid should include smoking cessation programs in their basic coverage.

During the first 5 years of the federal tobacco tax increase, all of the additional funds raised through it should go for programs to benefit farmers and their communities, the commission said. During the second 5 years, the money should support state prevention and cessation programs and other tobacco-related public health efforts.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“Everyone—patients, doctors—we all want the same thing. We want [patients] to live longer,” said Kiran Turaga, MD, MPH, on patients with peritoneal surface malignancies.
Data from the phase 3 DeLLphi-304 trial at ASCO 2025 revealed a survival advantage with tarlatamab vs chemotherapy in second-line ES-SCLC.
The new peritoneal surface malignancy care guidelines had clinicians gather from every disease state to show increased representation.
The FDA approval of tarlatamab in SCLC has received much press attention, according to Daniel R. Carrizosa, MD, MS.
These new guidelines aim to alleviate some of the problems caused by patients with peritoneal metastases being diagnosed with the disease in late stages.
A combined cohort composed of patients from the TROPION-Lung01 and TROPION-Lung-05 trials showed a survival advantage with dato-DXd vs docetaxel.
The National ICE-T Conference may inspire future collaboration between community and academic oncologists in the management of different cancers.
4 experts in this video